Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2844999 | 1.00 | SPHK1 (0.31) | SPHK1 | |
| SCHEMBL2316548 | 1.00 | SPHK1 (0.31) | SPHK1 | |
| SCHEMBL27847187 | 0.95 | SPHK1 (0.30) | SPHK1 | |
| SCHEMBL27847189 | 0.95 | SPHK1 (0.30) | SPHK1 | |
| SCHEMBL16053531 | 0.94 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL3213303 | 0.90 | — | — | |
| SCHEMBL3213291 | 0.90 | — | — | |
| SCHEMBL2867213 | 0.86 | SPHK1 (0.30) | SPHK1 | |
| SCHEMBL3226859 | 0.86 | SPHK1 (0.30) | SPHK1 | |
| SCHEMBL18938507 | 0.84 | SPHK1 (0.42) | SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796272-B2 | Glycine transporter-inhibiting substances | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20130331571-A1 | GLYCINE TRANSPORTER-INHIBITING SUBSTANCES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2013-12-12 | — | — | US | disclosed |
| US-20100063013-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130331571-A1 | GLYCINE TRANSPORTER-INHIBITING SUBSTANCES | SLC1A2, SLC18A2, SLC6A1 | SPHK1 4100/4885 |
| US-20100063013-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | CTSS, CTSB, CTSZ | SPHK1 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.